Literature DB >> 11789486

Headache and memory loss: rapid response to heparin in the antiphospholipid syndrome.

G R Hughes1, M J Cuadrado, M A Khamashta, G Sanna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11789486     DOI: 10.1177/096120330101001103

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  6 in total

1.  Autonomic neuropathy-in its many guises-as the initial manifestation of the antiphospholipid syndrome.

Authors:  Jill R Schofield
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 2.  Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

Authors:  Mohammad Hassan A Noureldine; Ali A Haydar; Ahmad Berjawi; Rody Elnawar; Ahmad Sweid; Munther A Khamashta; Graham R V Hughes; Imad Uthman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 3.  Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management.

Authors:  Dominic Seet; Nur Azizah Allameen; Jiacai Cho; Anselm Mak; Sen Hee Tay
Journal:  Rheumatol Ther       Date:  2021-05-15

4.  Deep capillary retinal ischemia and high-titer prothrombin-associated antiphospholipid antibodies: A case series of three patients.

Authors:  Jill R Schofield; Alan G Palestine; Victoria Pelak; Marc T Mathias
Journal:  Am J Ophthalmol Case Rep       Date:  2019-04-02

Review 5.  Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.

Authors:  César Magro-Checa; Elisabeth J Zirkzee; Tom W Huizinga; Gerda M Steup-Beekman
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

Review 6.  Neuropsychiatric Manifestations of Antiphospholipid Syndrome-A Narrative Review.

Authors:  Yik Long Man; Giovanni Sanna
Journal:  Brain Sci       Date:  2022-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.